Effect of combined administration of aripiprazole and fluoxetine on cognitive functions in female rats exposed to ethyl alcohol

• Autorzy: Kus K. , Ratajczak P. , Czaja N. , Zaprutko T. , Nowakowska E.
• Języki publikacji: EN

Abstrakty

EN

Alcoholism is a chronic and recurrent disease. The studies on ethyl alcohol show a progressive deterioration of cognitive functions (motor hyperactivity, operating memory). The aim of the study was to establish whether combined single and chronic administration of aripiprazole (ARI) and fluoxetine (FLU) affects animal locomotor activity or modifies spatial memory functions in female rats exposed to ethyl alcohol. Female Wistar rats were studied in the Morris Water Maze (MWM) and locomotor activity test. Rats undergoing the MWM and locomotor activity test were injected with saline on day 1, 7, 14 and 21 of testing. Results showed a statistically significant mobility increase in the group of ethanol‑exposed females (CEt) (21 days) compared to the non‑ethanol‑exposed group (CNEt). Upon ARI administration to CEt, no statistically significant differences in animal mobility were found, either upon single or chronic administration. Chronic administration of FLU (21 days) as well as combined administration of ARI+FLU (14 and 21 days) caused a statistically significant reduction of the females’ mobility compared to the control CEt group. Single and chronic administration of ARI (7x) both show a spatial memory improvement in CEt. No memory improvement was observed, however, after 14 and 21 days of ARI administration. FLU, likewise, improved spatial memory both upon single and chronic administration. Combined administration of ARI+FLU improved memory in CEt only upon single administration. Lack of effect upon chronic administration may be due to tolerance to memory improvement developing upon combined administration of ARI+FLU. It can be concluded that ARI (1.5 mg/kg), FLU (5 mg/kg), and combined administration of these drugs improves spatial memory in CEt.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2017
• Tom: 77
• Numer: 1
• Opis fizyczny: p.86-93,ref.

Twórcy

autor

Kus K.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Ratajczak P.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Czaja N.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Zaprutko T.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Nowakowska E.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

Bibliografia

• Allsop S, Saunders B, Phillips M, Carr A (1997) A trial of relapse prevention with severely dependent male problem drinkers. Addiction 92(1): 61–73.
• Beirle I, Meibohm B, Derendorf H (1999) Gender differences in pharmacokinetics and pharmacodynamics. Int J  Clin Pharmacol Ther 37(11): 529–547.
• Boerngen‑Lacerda R, Souza‑Formigoni ML (2000) Does the increase in locomotion induced by ethanol indicate its stimulant or anxiolytic properties?. Pharmacol Biochem Behav 67(2): 225–232.
• Burda K, Czubak A, Kus K, Nowakowska E, Ratajczak P, Zin J (2011) Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacol Rep 63(4): 898–907.
• Burda‑Malarz K, Kus K, Ratajczak P, Czubak A, Hardyk S, Nowakowska E (2014a) Evaluation of the antidepressant, anxiolytic and memory‑improving efficacy of aripiprazole and fluoxetine in ethanol‑treated rats. Drug Chem Toxicol 37(3): 281–289.
• Burda‑Malarz K, Kus K, Ratajczak P, Czubak A, Nowakowska E, Jędrzejewski  L, Sadowski C (2014b) Evaluation of the antidepressant and memory‑improving efficacy of aripiprazole and fluoxetine in alcohol‑preferring rats. Acta Neuropsychiatr 26(2): 112–119.
• Cacace S, Plescia F, Sardo P, Cannizzaro C (2012) Alcohol preference, behavioural reactivity and cognitive functioning in female rats exposed to a three‑bottle choice paradigm. Behav Brain Res 234(1): 11–19.
• Chun‑Fu WU, Wen L, Jing L, Chyon‑Hwa Y (1998) dl‑Fenfluramine inhibits ethanol‑induced ascorbic acid release in rat striatum studied by microdialysis. Addict Biol 3(3): 295–308.
• Diana M, Brodie M, Muntoni A, Puddu MC, Pillolla G, Steffensen S, Spiga S, Little HJ (2003) Enduring effects of chronic ethanol in the CNS: basis for alcoholism. Alcohol Clin Exp Res 27(2): 354–361.
• Dyr W (2001) Locomotor activity and the mechanism of ethanol action (in Polish). Alkohol Narkom 14(2): 207–212.
• Eckardt MJ, File SE, Gessa GL, Grant KA, Guerri C, Hoffman PL, Kalant H, Koob  GF, Li T‑K, Tabakoff B (1998) Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 22(5): 998–1040.
• Frezza M, Di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS (1990) High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first‑pass metabolism. N Engl J Med 322(2): 95–99.
• Gavaler JS, Arria AM (1995) Increased susceptibility of women to alcoholic liver disease: Artifactual or real? In: Alcoholic Liver Disease: Pathology and Pathogenesis (2nd ed.) (Hall P, Ed.). CRC Press, London, UK. p. 123–133.
• Gobert A, Rivet JM, Cistarelli  L, Millan MJ (1997) Potentiation of the fluoxetine‑induced increase in dialysate levels of serotonin (5‑HT) in the frontal cortex of freely moving rats by combined blockade of 5‑HT1A and 5‑HT1B receptors with WAY 100.635 and GR 127.935. J Neurochem 68(3): 1159–1163.
• Gudayol‑Ferré E, Guàrdia‑Olmos J, Peró‑Cebollero  M (2015) Effects of remission speed and improvement of cognitive functions of depressed patients. Psychiatry Res 226(1): 103–112.
• Guerrini I, Cook CC, Kest W, Devitgh A, McQuillin A, Curtis D, Gurling HM (2005) Genetic linkage analysis supports the presence of two susceptibility loci for alcoholism and heavy drinking on chromosome 1p22.1‑11.2 and 1q21.3‑24.2. BMC Genet 6: 11.
• Holladay JW, Dewey MJ, Yoo SD (1998) Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha‑1‑acid glycoprotein levels. Drug Metab Dispos 26(1): 20–24.
• Hommer D, Momenan R, Rawlings R, Ragan P, Williams W, Rio D, Eckardt M (1996) Decreased corpus callosum size among alcoholic women. Arch Neurol 53(4): 359–363.
• Ingamna K, Kupila J, Hyytia P, Korpi E (2006) Effects of aripiprazole on alcohol intake in an animal model of high‑alcohol drinking. Alcohol Alcohol 41(4): 391–398.
• Inoue A, Seto M, Sugita S, Hide L, Hirose T, Koga N, Kikuchi T, Nakata Y (1998) Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain Res Mol Brain Res 55(2): 285–292.
• June HL, Lewis MJ (1994) Interactions of ROJ5‑4513, ROJ5‑J788 (flumazenil) and ethanol on measures of exploration and locomotion in rats. Psychopharmacology (Berl) 116(3): 309–316.
• Klomp A, Vaclavu  L, Meerhoff GF, Reneman  L, Lucassen PJ (2015) Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. PLoS One 10(8): e0135876.
• Kohen I, Lester PE, Lam S (2010) Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. Neuropsychiatr Dis Treat 6: 47–58.
• Koren G (2012) Sex dependent pharmacokinetics and bioequivalence – time for change. J Popul Ther Clin Pharmacol 20(3): e358–e361.
• Kwo PY, Ramchandani VA, O’Connor S, Amann D, Carr LG, Sandrasegaran K, Kopecky KK, Li TK (1998) Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass. Gastroenterology 115(6): 1552–1557.
• Li TK, Beard JD, Orr WE, Kwo PY, Ramchandani VA (1998) Gender and ethnic differences in alcohol metabolism. Alcohol Clin Exp Res 22(3): 771–772.
• Li WL, Cai HH, Wang B, Chen L, Zhou QG, Luo CX, Liu N, Ding XS, Zhu DY (2009) Chronic fluoxetine treatment improves ischemia‑induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 87(1): 112–122.
• Lieber CS (1999) Microsomal ethanol‑oxidizing system (MEOS): the first 30 years (1958–1998) – a review. Alcohol Clin Exp Res 23(6): 991–1007.
• Lieber CS (2004) The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metabolism Rev 36(3–4): 511–529.
• Loftis JM, Wall JM, Pagel RL, Hauser P (2006) Administration of pegylated interferon‑alpha‑2a or ‑2b does not induce sickness behavior in Lewis rats. Psychoneuroendocrinology 31(10): 1289–1294.
• Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ (1999) Gender‑related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther 66(6): 594–601.
• Malinowska  M, Niewiadomska  M, Wesierska  M (2016) Spatial memory formation differentially affects c‑Fos expression in retrosplenial areas during place avoidance training in rats. Acta Neurobiol Exp (Wars) 76(3): 244–265.
• Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava  M, Simon JS, Trivedi MH, Thase ME, Berman RM (2008) The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a  second multicenter, randomized, double‑blind, placebo‑controlled study. J Clin Psychopharmacol 28(2): 156–165.
• McGavin JK, Goa KL (2002) Aripiprazole. CNS Drugs 16(11): 779–786.
• Morris BJ, Millan MJ, Herz A (1988) Antagonist‑induced opioid receptor up‑regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. J Pharmacol Exp Ther 247(2): 729–736.
• Muzina DJ (2009) Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole. Neuropsychiatr Dis Treat 5: 279–288.
• Newman‑Tancredi A, Chaput C, Verriele  L, Millan MJ (1996) Clozapine is a  partial agonist at cloned, human serotonin5‑HT1A receptors. Neuropharmacology 35(1): 119–121.
• NIAAA (1990) Alcohol and women. Alcohol Alert 10(290). https://pubs. niaaa.nih.gov/publications/aa10.htm. NIAAA (2001) Cognitive impairment and recovery from alcoholism. Alcohol Alert 53. https://pubs.niaaa.nih.gov/publications/aa53.htm. Noorafshan A, Abdollahifar MA, Asadi‑Golshan R, Rashidian‑Rashidabadi A, Karbalay‑Doust S (2014) Curcumin and sertraline prevent the reduction of the number of neurons and glial cells and the volume of rats’ medial prefrontal cortex induced by stress. Acta Neurobiol Exp (Wars) 74(1): 44–53.
• Okulicz‑Kozaryn I, Mikolajczak P, Kaminska E, Kaminska I, Szulc  M, Bobkiewicz‑Kozlowska T (2004) Effect of naltrexone administration on short‑term memory in chronically ethanol‑treated outbred rats. Alcohol Alcohol 39(1): 14–19.
• Owen R, Sikich  L, Marcus RN, Corey‑Lisle P, Manos G, McQuade RD, Carson WH, Findling RL (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6): 1533–1540.
• Pietrzak B, Dunaj A, Piątkowska K (2011) The role of the cannabinoid system in the pathogenesis and treatment of alcohol dependence. Postepy Hig Med Dosw (Online) 65: 606–615.
• Preskorn SH (2003) Relating clinical trials to psychiatric practice: part I: the case of a 13‑year old on aripiprazole and fluoxetine. J Psychiatr Pract 9(4): 307–313.
• Quintanilla ME (1999) Effect of low doses of ethanol on spontaneous locomotor activity in UChB and UChA rats. Addict Biol 4(4): 443–448.
• Ratajczak P, Kus K, Jarmuszkiewicz Z, Woźniak A, Cichocki M, Nowakowska E (2013) Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period. Pharmacol Rep 65(1): 30–43.
• Ratajczak P, Kus K, Jarmuszkiewicz Z, Woźniak A, Nowakowska E (2012) The effect of ethyl alcohol on the function of spatial memory in rats. Arzneimittelforschung 62(12): 614–623.
• Ratajczak P, Kus K, Murawiecka P, Słodzisnka I, Giermaziak  W, Nowakowska E (2015) Biochemical and cognitive impairments observed in animal models of schizophrenia induced by prenatal stress paradigm or methylazoxymethanol acetate administration. Acta Neurobiol Exp (Wars) 75(3): 314–325.
• Richtand NM, Ahlbrand R, Horn P, Tambyraja R, Grainger M, Bronson SL, McNamara RK (2012) Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiol Behav 106(2): 171–177.
• Risinger PO, MaIott DH, Prather LK, Niehus DR, Cunningham CL (1994) Motivational properties of ethanol in mice selectively bred for ethanol‑induced locomotor differences. Psychopharmacology (Berl) 116(2): 207–216.
• Robinson GE (2002) Women and psychopharmacology. Medscape Women’s Health eJournal 7(1): 264–266.
• Semba J, Watanabe A, Kito S, Toru M (1995) Behavioural and neurochemical effects of, a  novel antipsychotic drug OPC‑14597, on dopaminergic mechanisms in rat brain. Neuropharmacology 34(7): 785–791.
• Sesack SR, Carr DB (2002) Selective prefrontal cortex inplus to dopamine celIs: implications for schizophrenia. Physiol Behav 77(4–5): 513–517.
• Szymańska M, Budziszewska B, Jaworska‑Feil L, Basta‑Kaim A, Kubera M, Leśkiewicz M, Regulska M, Lasoń W (2009) The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 34(6): 822–832.
• Taylor JL, Dolhert N, Friedman  L, Mumenthaler  M, Yesavage JA (1996) Alcohol elimination and simulator performance of male and female aviators: a preliminary report. Aviat Space Environ Med 67(5): 407–413.
• Tuyns AJ, Pequignot G (1984) Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 13(1): 53–57.
• Uzbay IT, Sag Lam E, Kayir H, Celik T, Beyazyurek  M (2004) Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiatr Res 38(4): 445–450.
• Waller MB, Murphy JM, McBride WJ, Lumeng L, Li TK (1986) Effect of law dose ethanol on spontaneous motor activity in alcohol‑preferring and ‑nonpreferring lines of rats. Pharmacol Biochem Behav 24(3): 617–623.
• Wilson AW, Neill JC, Costall B (1998) An investigation into the effects of 5‑HT agonists and receptor antagonists on ethanol self‑administration in the rat. Alcohol 16(3): 249–270.
• Wilson K (1984) Sex‑related differences in drug disposition in man. Clin Pharmacokinet 9(3): 189–202.
• Zając M, Pawełczyk E, Jelińska A (2006) Medicinal chemistry for pharmacy students and pharmacists (in Polish). University of Medical Science, Poznan, Poland. p. 41–120.